insight
← 뒤로

Minimally Invasive Aesthetic Treatments for the Corrective Patient Archetype: Transforming Lives.

Aesthetic plastic surgery 2026

Shturman I, Garzón H, Coimbra D, Villafranca J, Zimbres S, de Los Angeles Pyke M, Van Der Graaff I, Dabronzo ML

원문 ↗ DOI ↗

관련 도메인

히알루론산 Hyaluronic Acid 보툴리눔독소 주사 Botulinum Toxin Injection 필러 주입술 Filler Injection

Abstract

[BACKGROUND] The definition of health encompasses mental, emotional, and social well-being, rather than simply the absence of disease. As a result, corrective aesthetic treatments are increasingly being viewed as an integral component of overall health rather than confined solely to the domain of aesthetics. In the realm of facial aesthetics, the corrective patient archetype is distinctly focused on rebalancing or proportioning facial features to improve confidence and self-perception. Minimally invasive treatments, such as botulinum toxin and hyaluronic acid (HA) gels, are known for their efficacy, tolerability, and ability to improve psychological and social outcomes. Additionally, hybrid injectables are gaining traction for their immediate filling and lifting effects that also provide biostimulating effects over time in the injected area.

[METHODS] Here, we present a clinical review of the literature, accompanied by examples that illustrate the practical application of onabotulinumtoxinA, HA gels, and hybrid injectables (HA and calcium hydroxyapatite; Allergan Aesthetics, an AbbVie Company) for patients seeking corrections, including facial asymmetries (e.g., facial paralysis and hemifacial microsomia), trauma, and scarring, emphasizing the importance of tailored approaches to achieve optimal outcomes.

[RESULTS AND CONCLUSIONS] OnabotulinumtoxinA, HA gels, and hybrid injectables were effective, tolerable, and enhanced patients' quality of life by addressing both aesthetic and functional concerns. Overall, further research is needed to refine these treatments and expand their applications in corrective aesthetic medicine.

[LEVEL OF EVIDENCE IV] This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors  www.springer.com/00266 .

추출된 의학 개체 (NER)

유형영어 표현한국어 / 풀이UMLS CUI출처등장
재료 ha 히알루론산 dict 4
시술 botulinum toxin 보툴리눔독소 주사 dict 1
해부 hybrid injectables scispacy 1
합병증 facial scispacy 1
재료 hyaluronic acid 히알루론산 dict 1
약물 calcium hydroxyapatite C0115137
durapatite
 scispacy 1
약물 [BACKGROUND] scispacy 1
약물 onabotulinumtoxinA scispacy 1
약물 calcium scispacy 1
약물 [RESULTS AND scispacy 1
질환 paralysis C0522224
Paralysed
 scispacy 1
질환 hemifacial microsomia C0265240
Goldenhar Syndrome
 scispacy 1
질환 trauma C0043251
Wounds and Injuries
 scispacy 1
질환 disease scispacy 1
질환 hybrid injectables scispacy 1
기타 Patient scispacy 1
기타 hybrid injectables scispacy 1
기타 patients scispacy 1

📑 인용 관계

이 논문이 참조한 문헌 46

외부 PMID 26건 (DB 미수집)

🔗 함께 등장하는 도메인

이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들

유방 (22) 안검성형술 (22) 코성형술 (21) 안면거상술 (21) 지방흡입 (19) 감염 (17) 유방성형술 (13) 피하조직 (12)

관련 논문